NO20001584D0 - Aminoterminert trunkert MCP-2 som kjemokinantagonister - Google Patents

Aminoterminert trunkert MCP-2 som kjemokinantagonister

Info

Publication number
NO20001584D0
NO20001584D0 NO20001584A NO20001584A NO20001584D0 NO 20001584 D0 NO20001584 D0 NO 20001584D0 NO 20001584 A NO20001584 A NO 20001584A NO 20001584 A NO20001584 A NO 20001584A NO 20001584 D0 NO20001584 D0 NO 20001584D0
Authority
NO
Norway
Prior art keywords
amino
chemokine antagonists
truncated mcp
terminated
terminated truncated
Prior art date
Application number
NO20001584A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001584L (no
Inventor
Paul Proost
Sofie Struyf
Jo Van Damme
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8227408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20001584(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20001584D0 publication Critical patent/NO20001584D0/no
Publication of NO20001584L publication Critical patent/NO20001584L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4813—Exopeptidases (3.4.11. to 3.4.19)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20001584A 1997-09-29 2000-03-27 Aminoterminert trunkert MCP-2 som kjemokinantagonister NO20001584L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP97116863A EP0906954A1 (de) 1997-09-29 1997-09-29 Aminoterminalen verkürzten C-C Chemokine als Chemokine Antagonist
EP97122471A EP0905240A1 (de) 1997-09-29 1997-12-19 Aminoterminalen verkürzten C-C-chemokine and als chemokine Antagonist
EP98104216A EP0905241A1 (de) 1997-09-29 1998-03-10 Aminoterminalen verkürzten C-C Chemokine und als Chemokine Antagonist
PCT/EP1998/006143 WO1999016877A1 (en) 1997-09-29 1998-09-28 Amino-terminally truncated rantes as chemokine antagonists

Publications (2)

Publication Number Publication Date
NO20001584D0 true NO20001584D0 (no) 2000-03-27
NO20001584L NO20001584L (no) 2000-03-27

Family

ID=8227408

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20001584A NO20001584L (no) 1997-09-29 2000-03-27 Aminoterminert trunkert MCP-2 som kjemokinantagonister
NO20001609A NO20001609L (no) 1997-09-29 2000-03-28 Aminoterminert trunkerte RANTES som kjemokinantagonister

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20001609A NO20001609L (no) 1997-09-29 2000-03-28 Aminoterminert trunkerte RANTES som kjemokinantagonister

Country Status (29)

Country Link
US (5) US6905676B2 (de)
EP (6) EP0906954A1 (de)
JP (2) JP4230659B2 (de)
KR (2) KR100542934B1 (de)
CN (3) CN1148447C (de)
AR (2) AR013529A1 (de)
AT (3) ATE264390T1 (de)
AU (2) AU750341B2 (de)
BG (2) BG64679B1 (de)
BR (2) BR9812394A (de)
CA (2) CA2305017A1 (de)
CY (1) CY1110927T1 (de)
CZ (2) CZ299479B6 (de)
DE (3) DE69823218T2 (de)
DK (3) DK1019507T3 (de)
EA (2) EA003940B1 (de)
EE (2) EE200000152A (de)
ES (3) ES2287601T3 (de)
HK (3) HK1062637A1 (de)
HU (2) HU226468B1 (de)
IL (2) IL135351A (de)
NO (2) NO20001584L (de)
NZ (3) NZ503234A (de)
PL (2) PL197569B1 (de)
PT (3) PT1021541E (de)
SK (2) SK286439B6 (de)
UA (2) UA73081C2 (de)
WO (2) WO1999016877A1 (de)
ZA (2) ZA988675B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6534626B1 (en) * 1997-12-01 2003-03-18 The United States Of America As Represented By The Department Of Health & Human Services Chemokine variants
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
EP1167527A1 (de) * 2000-06-22 2002-01-02 Euroscreen S.A. Prozessierte Menschliche Chemokine: PHC-1 und PHC-2
DE60030749T2 (de) * 1999-10-25 2007-09-20 Pharis Biotec Gmbh Prozessiertes menschliches chemokin phc-1
WO2001036459A2 (en) * 1999-11-15 2001-05-25 Forssmann Wolf Georg Novel use of hcc-2
CA2316405A1 (en) * 2000-05-26 2001-11-26 Ian Clark-Lewis Modulation of inflammation by protease products
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
UA77950C2 (en) * 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis
GB2373785A (en) * 2001-03-28 2002-10-02 Rega Inst For Medical Res Truncating chemokines using dipeptidyl peptidase IV
WO2003051921A1 (en) 2001-12-17 2003-06-26 Applied Research Systems Ars Holding N.V. Chemokine mutants acting as chemokine antagonists
EP1631680A2 (de) * 2003-05-21 2006-03-08 Bayer HealthCare AG Diagnostika und therapeutika für dipeptidylpeptidase iv (dpp4) assoziierte erkrangkungen
DE102005049637A1 (de) * 2005-10-14 2007-04-26 Rheinisch-Westfälische Technische Hochschule Aachen Antagonisten gegen die Interaktion von PF4 und RANTES
US8012474B2 (en) 2007-08-02 2011-09-06 Nov Immune S.A. Anti-RANTES antibodies
US20130053257A1 (en) * 2010-02-08 2013-02-28 Paul E. Oran RANTES Multiplexed Assay, RANTES Variants Related to Disease, and RANTES Variants Related to Enzymatice Activity
US9296803B2 (en) 2010-03-11 2016-03-29 Health Research, Inc. Methods and compositions containing Fc fusion proteins for enhancing immune responses
TW201718851A (zh) * 2015-09-18 2017-06-01 通用醫院公司 具有抗化學排斥(anti-fugetactic)性質之經修飾自然殺手細胞及其用途
CN112469430A (zh) 2018-05-28 2021-03-09 日内瓦大学 抑制大脑炎症的方法
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
US11402391B2 (en) 2020-12-21 2022-08-02 Incelldx, Inc. Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01265099A (ja) 1987-10-08 1989-10-23 Stichting Rega Vzw 抗ｈｉｖ活性をもつ３’，−フルオロプリン−２’，３’−ジデオキシリボシド類
US5739103A (en) * 1993-11-12 1998-04-14 Dana-Farber Cancer Institute Chemokine N-terminal deletion mutations
AU688641B2 (en) * 1994-12-08 1998-03-12 Glaxo Group Limited Rantes peptide and fragments and compositions comprising it for treatment of inflammation
WO1997025427A1 (en) * 1996-01-12 1997-07-17 Genetics Institute, Inc. Beta-chemokine, h1305 (mcp-2)
AU733925C (en) * 1996-03-27 2002-06-13 Icos Corporation Monocyte chemotactic protein-5 materials and methods
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
US6168784B1 (en) * 1997-09-03 2001-01-02 Gryphon Sciences N-terminal modifications of RANTES and methods of use

Also Published As

Publication number Publication date
HU226414B1 (en) 2008-11-28
CN1271385A (zh) 2000-10-25
US20030124677A1 (en) 2003-07-03
ES2218860T3 (es) 2004-11-16
HK1062637A1 (en) 2004-11-19
CN1271386A (zh) 2000-10-25
JP2001518296A (ja) 2001-10-16
AU750606B2 (en) 2002-07-25
JP4233214B2 (ja) 2009-03-04
ZA988675B (en) 1999-11-24
BG104266A (en) 2000-11-30
CZ299478B6 (cs) 2008-08-06
NZ503235A (en) 2002-08-28
BG64757B1 (bg) 2006-02-28
EP1439231A2 (de) 2004-07-21
DK1019507T3 (da) 2004-07-19
EA003940B1 (ru) 2003-10-30
IL135351A (en) 2006-08-20
KR100542934B1 (ko) 2006-01-11
US7326411B2 (en) 2008-02-05
SK286439B6 (sk) 2008-10-07
PT1019507E (pt) 2004-06-30
EP0905241A1 (de) 1999-03-31
AU750341B2 (en) 2002-07-18
EP1021541A1 (de) 2000-07-26
DE69838188T2 (de) 2007-11-22
CN1148447C (zh) 2004-05-05
DE69823218D1 (de) 2004-05-19
EP0906954A1 (de) 1999-04-07
CY1110927T1 (el) 2015-06-10
HU226468B1 (en) 2008-12-29
US20050201977A1 (en) 2005-09-15
NO20001609D0 (no) 2000-03-28
NZ503234A (en) 2002-06-28
BR9812394A (pt) 2000-09-12
ATE264390T1 (de) 2004-04-15
CZ20001146A3 (cs) 2000-09-13
DE69822856D1 (de) 2004-05-06
BG104267A (en) 2000-11-30
EE200000152A (et) 2001-02-15
EP1021541B1 (de) 2004-04-14
EA200000379A1 (ru) 2000-10-30
NO20001609L (no) 2000-03-28
HUP0003563A2 (hu) 2001-02-28
KR20010024213A (ko) 2001-03-26
DK1439231T3 (da) 2007-11-05
EP1019507B1 (de) 2004-03-31
ATE368742T1 (de) 2007-08-15
HK1032425A1 (en) 2001-07-20
JP4230659B2 (ja) 2009-02-25
IL135352A (en) 2006-08-20
AR013528A1 (es) 2000-12-27
DE69823218T2 (de) 2004-08-26
CN1145693C (zh) 2004-04-14
AR013529A1 (es) 2000-12-27
CN1490049A (zh) 2004-04-21
CA2304827A1 (en) 1999-04-08
DE69822856T2 (de) 2004-08-19
US6905676B2 (en) 2005-06-14
PL196427B1 (pl) 2008-01-31
UA73080C2 (en) 2005-06-15
HUP0003563A3 (en) 2005-11-28
US20050220790A1 (en) 2005-10-06
BR9812565A (pt) 2000-08-01
HK1032426A1 (en) 2001-07-20
EA003942B1 (ru) 2003-10-30
AU9747498A (en) 1999-04-23
ES2287601T3 (es) 2007-12-16
WO1999016877A1 (en) 1999-04-08
EP1439231A3 (de) 2004-12-22
CA2305017A1 (en) 1999-04-08
KR20010024214A (ko) 2001-03-26
PL339559A1 (en) 2000-12-18
DE69838188D1 (de) 2007-09-13
AU9442098A (en) 1999-04-23
SK4502000A3 (en) 2000-09-12
UA73081C2 (en) 2005-06-15
NO20001584L (no) 2000-03-27
ATE263242T1 (de) 2004-04-15
PT1439231E (pt) 2007-08-20
SK286495B6 (sk) 2008-11-06
ZA988676B (en) 1999-12-03
WO1999016876A1 (en) 1999-04-08
CZ20001147A3 (cs) 2000-09-13
CZ299479B6 (cs) 2008-08-06
HUP0003505A2 (hu) 2001-02-28
DK1021541T3 (da) 2004-08-02
EA200000378A1 (ru) 2000-10-30
SK4512000A3 (en) 2000-09-12
EP1439231B1 (de) 2007-08-01
US20030119148A1 (en) 2003-06-26
BG64679B1 (bg) 2005-11-30
US20050164936A1 (en) 2005-07-28
PL197569B1 (pl) 2008-04-30
US7338653B2 (en) 2008-03-04
EP0905240A1 (de) 1999-03-31
EP1019507A1 (de) 2000-07-19
NZ516027A (en) 2003-05-30
ES2215324T3 (es) 2004-10-01
CN1233415C (zh) 2005-12-28
PT1021541E (pt) 2004-07-30
PL339545A1 (en) 2000-12-18
JP2001518297A (ja) 2001-10-16
US6977071B2 (en) 2005-12-20
EE200000151A (et) 2001-02-15
HUP0003505A3 (en) 2005-11-28
KR100560275B1 (ko) 2006-03-10

Similar Documents

Publication Publication Date Title
NO20001584D0 (no) Aminoterminert trunkert MCP-2 som kjemokinantagonister
NO972526D0 (no) Tachykininantagonister
DE69823694T2 (de) Thrombin-rezeptor antagonisten
DK0871623T3 (da) 3-Azetinidylalkylpiperidiner eller -pyrrolidiner som tachykininantagonister
NO20002575D0 (no) Substituerte oksimer som neurokininantagonister
DE29722763U1 (de) Tischkonstruktion
DE29709963U1 (de) Geschirr-Set
DK0964867T3 (da) Tachykininantagonister
DE69706134D1 (de) Bondkopf
UA25677A (uk) Горілка
FI3380U1 (fi) Suojakatos
KR980004088U (ko) 보일러의 상판구조
IT243110Y1 (it) Struttura di tavolo
IT242690Y1 (it) Tappo di sughero
UA1563S (uk) Пляшка
UA1568S (uk) Флакон
UA1610S (uk) Пляшка
UA1565S (uk) Пляшка
UA1611S (uk) Пляшка
UA1576S (uk) Пляшка
UA1562S (uk) Пляшка
UA1621S (uk) Пляшка
DE29719656U1 (de) Flasche
UA1564S (uk) Пляшка
UA1570S (uk) Флакон

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application